Deep, qualified next-generation sequencing has unveiled that subclonal mutations (i.e., those present in only a fraction of tumor cells) is usually detected for all driver genes and they are related to fast disease progression and inadequate consequence.11–13 This is especially applicable for TP53 mutations specified The truth that, as discussed